Gareth Morgan, MD, FRCP, FRCPath, PhD from the University of Arkansas for Medical Sciences, Arkansas, AR discusses the current treatment landscape for high-risk multiple myeloma (MM) patients and what the next steps should be.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, held in Orlando, FL.
To see more videos go to http://www.vjhemonc.com/
Facebook: https://www.facebook.com/vjhemonc
Twitter: https://twitter.com/VJHemOnc
Advertisement